Moreover, in RA patients, receiving treatment with anti‐TNF therapy for the underlying rheumatic disease was significantly associated with lower odds of COVID‐19‐related hospitalization, in contrast to not receiving any anti‐TNF inhibitor therapy.33 Here, TNF is linked to COVID-19.